Cost effectiveness of a targeted age-based West Nile virus vaccination program.

CONCLUSIONS: Age-based WNV vaccination program targeting those at higher risk for severe disease is more cost-effective than universal vaccination. Annual variation in WNV disease incidence, QALY weights, and vaccine costs impact the cost effectiveness ratios. PMID: 28456529 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28456529?dopt=Abstract

Source: Vaccine - April 26, 2017 Category: Allergy & Immunology Authors: Shankar MB, Staples JE, Meltzer MI, Fischer M Tags: Vaccine Source Type: research